The MYCN 5′ UTR as a therapeutic target in neuroblastoma
Cell Reports · 2024-05 · 43 (5) · 114134
DOI: 10.1016/j.celrep.2024.114134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-05. Verfasst von Marina P Volegova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, …. Hauptthemen laut MEDLINE: 5' Untranslated Regions, Eukaryotic Initiation Factor-4A, N-Myc Proto-Oncogene Protein, Neuroblastoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
- Boston University, Center for Molecular Discovery (BU-CMD), Boston, MA, USA; Boston University, Department of Chemistry, Boston, MA, USA.
- Boston University School of Medicine, Computational Biomedicine, Boston, MA, USA.
- Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
- Boston Children's Cancer and Blood Disorders Center, Pediatric Hematology/Oncology, Boston, MA, USA.
- Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA. Electronic address: rani_george@dfci.harvard.edu.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NCATS NIH HHS
- National Institutes of Health
- Alex's Lemonade Stand Foundation for Childhood Cancer
Zitieren
APA
Volegova, M. P., Brown, L. E., Banerjee, U., Dries, R., Sharma, B., Kennedy, A., Porco, J. A., & George, R. E. (2024). The MYCN 5′ UTR as a therapeutic target in neuroblastoma. Cell Reports, 43(5), 114134. https://doi.org/10.1016/j.celrep.2024.114134
Vancouver
Volegova MP, Brown LE, Banerjee U, Dries R, Sharma B, Kennedy A, et al. The MYCN 5′ UTR as a therapeutic target in neuroblastoma. Cell Reports. 2024;43(5):114134. doi:10.1016/j.celrep.2024.114134
BibTeX
@article{Volegova2024,
author = {Volegova, Marina P and Brown, Lauren E and Banerjee, Ushashi and Dries, Ruben and Sharma, Bandana and Kennedy, Alyssa and Porco, John A and George, Rani E},
title = {The MYCN 5′ UTR as a therapeutic target in neuroblastoma},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {5},
pages = {114134},
doi = {10.1016/j.celrep.2024.114134}
}
EUVIMED